Muscular dystrophy drug discontinued in Canada, leaving B.C. families anxious
A drug for a rare form of muscular dystrophy will no longer be sold in Canada. The alternative costs far more and is not yet funded by the B.C. government.
Reported by the Vancouver Sun; confirmation from the B.C. government and the drug's maker pending.
Some B.C. families are anxious about their children's futures after a drug used to treat a rare form of muscular dystrophy was discontinued in Canada, the Vancouver Sun reported in an article published Nov. 18.
The drug will no longer be sold in the country. An alternative treatment exists, but it is far more expensive than the discontinued medication, and the B.C. government does not yet fund it, according to the Sun.
That puts a provincial coverage decision at the centre of the story for affected families in Vancouver and across the province. The cost of the alternative and the absence of public funding are what the newspaper linked to the families' worry.
The open question is whether B.C. will add the alternative drug to its funded list, and when.
Sources
Facts first. Context second. Sources always. This story was prepared with AI assistance from the sources listed above and reviewed by a Northline editor before publication. How we use AI · Report an error